BLCM Historical PE Ratio image   This BLCM PE ratio history page last updated 3/21/2023
BLCM PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/10/2022
1.13-0.23-0.50NA
Q2 2022
8/11/2022
1.42-0.13-0.20NA
Q1 2022
5/12/2022
1.43-0.25-0.29NA
Q4 2021
3/24/2022
2.010.11-1.12NA
Q3 2021
11/4/2021
2.050.07-0.09NA
Q2 2021
8/12/2021
3.07-0.22-0.34NA
Q1 2021
5/17/2021
2.99-1.08-7.93NA
Q4 2020
3/30/2021
3.381.14-5.76NA
Q3 2020
11/5/2020
2.86-0.18-12.72NA
Q2 2020
8/6/2020
7.49-7.81-19.34NA
Q1 2020
5/7/2020
5.581.09-17.33NA
Q4 2019
3/12/2020
5.91-5.82-23.92NA
Q3 2019
11/6/2019
12.80-6.80-24.40NA
Q2 2019
8/5/2019
13.00-5.80-23.10NA
Q1 2019
5/7/2019
31.50-5.50-23.30NA
Q4 2018
3/12/2019
32.70-6.30-24.60NA
Q3 2018
11/6/2018
45.20-5.50-24.40NA
Q2 2018
8/7/2018
60.60-6.00-26.00NA
Q1 2018
5/8/2018
68.60-6.80-27.40NA
Q4 2017
3/13/2018
80.80-6.10-28.60NA
Q3 2017
11/7/2017
97.50-7.10-29.90NA
Q2 2017
8/8/2017
107.10-7.40-29.40NA
Q1 2017
5/8/2017
123.10-8.00-28.10NA
Q4 2016
3/13/2017
140.90-7.40-25.70NA
Q3 2016
11/9/2016
192.80-6.60-24.60NA
Q2 2016
8/8/2016
170.50-6.10-23.10NA
Q1 2016
5/9/2016
94.10-5.60-21.00NA
Q4 2015
3/14/2016
100.30-6.30-18.40NA
Q3 2015
11/9/2015
167.60-5.10NANA
Q2 2015
8/13/2015
178.30-4.00NANA
Q1 2015
5/11/2015
249.60-3.00NANA
BLCM Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/10/2022
1.13-0.23-0.92NA
Q2 2022
8/11/2022
1.42-0.13-0.52NA
Q1 2022
5/12/2022
1.43-0.25-1.00NA
Q4 2021
3/24/2022
2.010.110.444.6
Q3 2021
11/4/2021
2.050.070.287.3
Q2 2021
8/12/2021
3.07-0.22-0.88NA
Q1 2021
5/17/2021
2.99-1.08-4.32NA
Q4 2020
3/30/2021
3.381.144.560.7
Q3 2020
11/5/2020
2.86-0.18-0.72NA
Q2 2020
8/6/2020
7.49-7.81-31.24NA
Q1 2020
5/7/2020
5.581.094.361.3
Q4 2019
3/12/2020
5.91-5.82-23.28NA
Q3 2019
11/6/2019
12.80-6.80-27.20NA
Q2 2019
8/5/2019
13.00-5.80-23.20NA
Q1 2019
5/7/2019
31.50-5.50-22.00NA
Q4 2018
3/12/2019
32.70-6.30-25.20NA
Q3 2018
11/6/2018
45.20-5.50-22.00NA
Q2 2018
8/7/2018
60.60-6.00-24.00NA
Q1 2018
5/8/2018
68.60-6.80-27.20NA
Q4 2017
3/13/2018
80.80-6.10-24.40NA
Q3 2017
11/7/2017
97.50-7.10-28.40NA
Q2 2017
8/8/2017
107.10-7.40-29.60NA
Q1 2017
5/8/2017
123.10-8.00-32.00NA
Q4 2016
3/13/2017
140.90-7.40-29.60NA
Q3 2016
11/9/2016
192.80-6.60-26.40NA
Q2 2016
8/8/2016
170.50-6.10-24.40NA
Q1 2016
5/9/2016
94.10-5.60-22.40NA
Q4 2015
3/14/2016
100.30-6.30-25.20NA
Q3 2015
11/9/2015
167.60-5.10-20.40NA
Q2 2015
8/13/2015
178.30-4.00-16.00NA
Q1 2015
5/11/2015
249.60-3.00-12.00NA
Quotes delayed 20 minutes

Email EnvelopeFree BLCM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Bellicum Pharmaceuticals (BLCM) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BLFS PE Ratio History
BLI PE Ratio History
BLPH PE Ratio History
BLUE PE Ratio History
BMEA PE Ratio History
BMRA PE Ratio History
BMRN PE Ratio History
BMY PE Ratio History
BNGO PE Ratio History
BOLT PE Ratio History
On this page we presented the BLCM PE Ratio History information for Bellicum Pharmaceuticals' stock. The average BLCM PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 3.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BLCM PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BLCM PE ratio history result, against the recent PE: when this page was posted on 3/20/2023, the most recent closing price for BLCM had been 0.32, and the most recent quarterly earnings result, annualized, was 0.44. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent BLCM PE on 3/20/2023 based on annualized quarterly EPS was 0.7. Based on BLCM's history, that recent PE is low relative to the historical average, with the recent PE 80.0% lower than the historical average PE across our data set for Bellicum Pharmaceuticals.

For self directed investors doing their due diligence on BLCM or any other given stock, valuation analysis for BLCM can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Bellicum Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for BLCM. Thanks for visiting, and the next time you need to research BLCM PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: MEDS shares outstanding history, BVL Historical Stock Prices, Top Ten Hedge Funds Holding CMII.

 

BLCM PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.